MedPath

Optimizing Diagnostics Of Arrhythmia Events In Children Using Intelligent Telemetric Solutions

Not Applicable
Conditions
Arrhythmia
Children
Interventions
Device: Prolonged telemetric Full Disclosure ECG recording.
Device: Repeated 24 hours ECG Holter monitoring
Registration Number
NCT01265771
Lead Sponsor
National Institute of Cardiology, Warsaw, Poland
Brief Summary

The purpose of this study is to assess efficacy of prolonged Full Disclosure electrocardiogram (ECG) monitoring and signal analysis using advanced telemetric technology to diagnose arrhythmia in comparison with standard diagnostic procedure.

Detailed Description

Irregular and/or rapid beating of the heart called heart palpitations can occur in individuals without heart disease and the reasons for their palpitations are unknown. Together with heart palpitations silent arrhythmia may be present that could lead to serious complications (eg. stroke). In others, palpitations result from heart rhythm disturbances, sometimes life threatening. Standard diagnostic methods such as 24 hours Holter electrocardiogram (ECG) monitoring or Event Holter do not guarantee early diagnosis of the arrhythmia. Prolonged heart rhythm recording and analysis using an automatic full disclosure telemetric device can increase probability of arrhythmia diagnosis and early administration of applicable treatment. Study patients will be diagnosed using standard Holter ECG monitoring, Event Holter or 30 days telemetric ECG monitoring. Efficacy of telemetric monitoring in diagnosis of cardiac arrhythmia will be assessed in comparison with the standard Holter monitoring and Event Holter

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
400
Inclusion Criteria
  • History of symptoms that can be potentially caused by cardiac arrhythmia occuring at least 4 times a year
  • Ability to operate the telemetric device at home
  • Informed consent undersigned by the parents
  • Informed consent undersigned by the child if over 16 years of age
Exclusion Criteria
  • Previously recorded tachycardia evidence
  • Wolff Parkinson White syndrome
  • Inability to operate the telemetric device at home
  • Inability to comply with the study protocol

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Telemetry ordered by a CardiologistProlonged telemetric Full Disclosure ECG recording.-
24 hours standard Holter monitoringRepeated 24 hours ECG Holter monitoring-
Telemetry ordered by a PediatricianProlonged telemetric Full Disclosure ECG recording.-
Primary Outcome Measures
NameTimeMethod
Recording of symptomatic or life threatening arrhythmia eventwithin 30 days since the start of monitoring

ECG monitoring is conducted until occurrence of symptomatic arrhythmia or life threatening arrhythmia but not longer than 30 days. Patients in the control group will have standard ECG Holter monitoring repeated twice

Secondary Outcome Measures
NameTimeMethod
Occurrence of silent (asymptomatic) arrhythmia eventwithin 30 days since the start of monitoring
Verification of patient self assessment based on the Quality of Life questionnaire and European Heart Rhythm Association (EHRA) scale against evidence of cardiac arrhythmia occurrencewithin 30 days since the start of monitoring

Trial Locations

Locations (3)

Institute of Cardiology

🇵🇱

Warsaw, Poland

Medical University of Warsaw Department of Pediatric Cardiology and General Pediatrics

🇵🇱

Warsaw, Poland

The Children's Memmorial Health Institute

🇵🇱

Warsaw, Poland

© Copyright 2025. All Rights Reserved by MedPath